- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
- 10-Q Quarterly report
- 10.1 Separation Agreement and Release - Frances. K. Heller
- 10.2 Change In Control and Severance Benefit Plan, As Amended and Restated.
- 10.3 Sublease Between Exelixis, Inc. and Nodality, Inc.
- 10.4 Consent to Sublease by HCP Life Sciences, Exelixis and Nodality, Inc.
- 10.5 Sublease Between Exelixis, Inc. and Threshold Pharmaceuticals, Inc.
- 10.6 Consent to Sublease by HCP Life Sciences, Exelixis and Threshold Pharmaceuticals
- 10.7 Amendment No. 11 to the Loan and Security Agreement
- 10.8 Severance/consulting Agreement and Release - Lupe M. Rivera
- 31.1 Certification Required by Rule 13A-14(A) or Rule 15D-14(A).
- 31.2 Certification Required by Rule 13A-14(A) or Rule 15D-14(A).
- 32.1 Certification by the CEO & CFO Required by 13A-14(B) or 15D-14(B) & Section 1350
Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Michael M. Morrissey, Chief Executive Officer of Exelixis, Inc. (the “Company”), and Frank Karbe, Chief Financial Officer of the Company, each hereby certifies, to his knowledge, that:
1. The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2011 (the “Periodic Report”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 27th day of October, 2011.
/s/ Michael M. Morrissey | /s/ Frank Karbe | |||
Michael M. Morrissey, Ph.D. President and Chief Executive Officer (Principal Executive Officer) | Frank Karbe Executive Vice President and Chief Financial Officer (Principal Financial Officer) |